Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 30, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

4SC's Partner Yakult Honsha Completes Phase I Part of Clinical Study with Resminostat in NSCLC Patients
Saturday, October 11, 2014
Phase I confirms safety and tolerability of resminostat/docetaxel combination in the planned dose regimen in Asian NSCLC patients.

New 'Lab-on-a-Chip' Could Revolutionize Early Diagnosis of Cancer
Friday, October 10, 2014
Faster result times, reduced costs, minimal sample demands and better sensitivity of analysis.

Dramatic Response And Resistance To Cancer Drug Traced
Friday, October 10, 2014
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.

Personalized Ovarian Cancer Vaccines
Thursday, October 09, 2014
UConn Researchers have found a new way to identify protein mutations in cancer cells.

First Pictures of BRCA2 Protein Show How it Works to Repair DNA
Thursday, October 09, 2014
Researchers purified the protein and used electron microscopy to reveal its structure.

NanoString, Brigham and Women’s Hospital Collaborate
Wednesday, October 08, 2014
Research collaboration to accelerate translation of genomic discoveries into clinical diagnostics in oncology.

ACD Awarded $1.4 Million NCI Grant
Wednesday, October 08, 2014
Two-year grant to develop ultrasensitive diagnostic test for B-Cell lymphoma.

ADC Therapeutics Expands Team
Wednesday, October 08, 2014
Company’s lead program, ADCT-301, to enter clinical development in early 2015.

Trelstar® Six-Month Dosing for Prostate Cancer Patients Launches in Canada
Wednesday, October 08, 2014
Trelstar® one-, three-, and six-month dosing options now available.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 3182
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv